More

    Finance

    UBS expects a comeback for the 60/40 portfolio — and wants to limit cash

    The 60/40 portfolio isn't dead — in fact, it tends to outperform over the long term, according to UBS. That means investors hiding...

    Oppenheimer lifts Xylem shares target, cites strong growth framework By Investing.com

    On Friday, Oppenheimer maintained a positive stance on Xylem (NYSE: NYSE:) shares, increasing the price target to $152 from the previous...

    Why the minimum wage and some tax breaks don’t budge despite inflation

    Martin Barraud | Ojo Images | Getty ImagesMany Americans are likely familiar with financial thresholds that are adjusted for inflation each year.They include...

    Citi Trends names Ken Seipel as interim CEO, releases Q1 results By Investing.com

    SAVANNAH, Ga. - Citi Trends, Inc. (NASDAQ: CTRN), a value retailer of apparel, accessories, and home trends, announced the appointment of Ken Seipel...

    Stock splits are all the rage with Nvidia the latest

    Stock splits have picked picked up in recent months. While stock splits don't affect a company's value, they can catalyze a move higher...

    Tech View: Nifty forms long-legged Doji candle. What should traders do inelection result week

    Nifty formed a long-legged Doji candle on the daily charts to breach a 5-day losing streak, ending 42 points higher at 22,531.The 50-DMA...

    ICON shares target lifted by TD Cowen on growth prospects By Investing.com

    On Friday, TD Cowen raised its price target on ICON plc (NASDAQ:ICLR) shares to $373 from $349, while keeping a Buy rating on...

    Trump’s fundraising site crashes after guilty verdict as both Biden and Trump campaigns use hush payment trial to drum up millions in donations

    The Republican party’s WinRed fundraising platform collapsed briefly on Thursday under the weight of grassroots donors rushing to support Donald Trump following his...

    Pfizer lung cancer drug shows promising long-term trial results

    CHICAGO — Pfizer on Friday said its drug for an advanced form of lung cancer showed promising long-term results in a late-stage trial,...

    Latest articles

    spot_imgspot_img